Cargando…
Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
Atypical protein kinase C (aPKC) are involved in progression of many human cancers. Vimentin is expressed during epithelial to mesenchymal transition (EMT). Molecular dynamics of Vimentin intermediate filaments (VIFs) play a key role in metastasis. This article is an effort to provide thorough under...
Autores principales: | Ratnayake, Wishrawana S., Apostolatos, Christopher A., Breedy, Sloan, Dennison, Clare L., Hill, Robert, Acevedo-Duncan, Mildred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889213/ https://www.ncbi.nlm.nih.gov/pubmed/33525953 http://dx.doi.org/10.1080/19336918.2021.1882782 |
Ejemplares similares
-
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
por: Ratnayake, Wishrawana S., et al.
Publicado: (2017) -
14-3-3 and Smad2/3 are crucial mediators of atypical-PKCs: Implications for neuroblastoma progression
por: Breedy, S., et al.
Publicado: (2023) -
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
por: Apostolatos, André H., et al.
Publicado: (2018) -
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
por: Apostolatos, André H., et al.
Publicado: (2019)